Lux Capital
Lux Capital is a venture capital firm established in 2000, with offices in New York City and Silicon Valley. The firm specializes in founding, seed, early-stage, and growth investments, primarily in the physical and life sciences, as well as sectors such as biochemistry, material science, aerospace, and advanced technologies like machine learning and synthetic biology. Lux Capital actively supports entrepreneurs in developing successful businesses, leveraging its extensive expertise to enhance the connectivity and competitive edge of its portfolio companies. With assets under management totaling approximately $4 billion, the firm has played a significant role in founding over 20 companies, focusing on high-growth opportunities and innovative solutions across diverse industries.
Perchwell is a fully integrated online residential real estate search and collaboration product.
Copia specializes in providing advanced tools for industrial automation, focusing on enhancing visibility and control for automation and control engineers. Its flagship product offers Git-based source control specifically designed for programmable logic controller (PLC) programming, which facilitates robust version control and change visibility. By streamlining processes related to quality control and production management, Copia's solutions enable clients to improve operational efficiency, minimize downtime, and manage potential crises proactively. The company's innovative approach aims to transform the industrial landscape through modern technology tailored for fund managers and administrators.
Copia specializes in providing advanced tools for industrial automation, focusing on enhancing visibility and control for automation and control engineers. Its flagship product offers Git-based source control specifically designed for programmable logic controller (PLC) programming, which facilitates robust version control and change visibility. By streamlining processes related to quality control and production management, Copia's solutions enable clients to improve operational efficiency, minimize downtime, and manage potential crises proactively. The company's innovative approach aims to transform the industrial landscape through modern technology tailored for fund managers and administrators.
Roam Research, Inc. is a company that develops a Software-as-a-Service (SaaS) platform designed for real-time collaboration, primarily focusing on notetaking and graph databases. Founded in 2017 and based in San Francisco, California, Roam Research aims to enhance the writing process as a means of improving thought organization and problem-solving capabilities. The platform facilitates users in connecting and collaborating with others while allowing them to intersect and combine notes across various domains. By providing tools that help users write and organize their ideas more effectively, Roam Research seeks to empower individuals to refine their thinking and address complex challenges.
Authorea is a provider of a collaborative platform that facilitates the reading, writing, discussion, and publication of research. Its platform functions as an advanced document editor tailored for researchers, offering features such as collaborative editing, automatic citation formatting, and change tracking. This enables researchers to work together efficiently, allowing them to attach references, figures, data, and source code to their documents. By enhancing communication throughout the research process, Authorea aims to improve the overall workflow for researchers and support breakthrough discoveries.
Capella Bioscience Limited is involved in the discovery and development of monoclonal antibodies (mAbs) for therapeutic applications. The company utilizes proprietary technologies to create and commercialize mAb-based medicines targeting oncology, autoimmune diseases, and other conditions. Founded in 2014 and headquartered in London, the firm operates both independently and in collaboration with biotechnology firms and academic institutions to advance its research and development efforts. Through its innovative approach, Capella Bioscience aims to contribute to the development of advanced medical therapies that address significant health challenges.
Experiment Inc. is an online crowdfunding platform dedicated to supporting scientific research across various disciplines, including biology, chemistry, medicine, and engineering. Founded in 2010 and based in San Francisco, the platform allows researchers to showcase their projects through videos and detailed descriptions, enabling them to raise funds from a diverse pool of contributors. Experiment connects researchers from over 150 institutions worldwide, facilitating partnerships with notable organizations such as Tulane University School of Medicine and the University of Washington. Originally established as Microryza Inc., the company rebranded to Experiment Inc. in 2014, reflecting its broader mission to engage the public in scientific discovery and innovation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.